Laurie Villanueva

Laurie Villanueva has been writing about consumer issues for over two decades, Her work for largely focuses on pharmaceutical and medical device safety, including the ongoing litigation surrounding Risperdal, proton pump inhibitors, Invokana, Levaquin, defective hip implants, the Bair Hugger forced air warming blanket, and IVC filters. Laurie has also devoted a great deal of coverage to women’s health issues, especially recent litigation involving talcum powder, power morcellators, transvaginal mesh, and breast implants.

Laurie graduated from Penn State University in 1990 with a degree in journalism. After spending many years covering local government for various print media outlets, she is now focused on utilizing the internet to raise awareness about important consumer issues.

Zantac Recall News: Novartis Stops Generic Ranitidine Shipments Amidst Cancer Scare

Although federal health regulators have declined to order a Zantac recall, at least one generic drug maker has decided to stop shipping product amid concern that ranitidine-containing medications might be contaminated with a cancer-causing chemical. On Wednesday, Novartis announced it … Continue reading

Clergy Sexual Abuse Lawsuits Force Rochester Catholic Diocese into Bankruptcy

The Roman Catholic Diocese of Rochester has filed for bankruptcy, as it struggles to cope with a wave of clergy sexual abuse lawsuits unleashed by the New York Child Victims Act. 264 Sex Abuse Claimants Among Rochester Diocese’s Creditors The … Continue reading

First Zantac Lawsuits Filed Over Cancer-Causing Chemical

Plaintiffs have already begun filing Zantac lawsuits in courts across the country, just day’s after the U.S. Food & Drug Administration (FDA) warned that prescription and over-the-counter versions of Zantac could be contaminated with a cancer-causing impurity. Zantac: What’s the … Continue reading

New Jersey Judge Allows Ethicon Hernia Mesh Claims to Move Forward

A New Jersey federal judge has declined to dismiss product liability and personal injury claims involving Ethicon, Inc.’s Prolene Hernia System Patch, as it’s not yet clear when the statute of limitations governing those claims actually began to run. Ethicon … Continue reading

Cancer-Causing Chemical Found in OTC and Prescription Zantac Products

A cancer-causing chemical has been detected in Zantac, the popular medication taken by millions of people to treat heart burn. While it’s unclear just how dangerous contaminated Zantac might be, the U.S. Food & Drug Administration (FDA) is urging those … Continue reading

Ethicon Surgical Stapler Lawsuit Blames Redesign for Malfunctions, Resulting Complications

A Louisiana man has filed a new surgical stapler lawsuit against Ethicon, Inc., asserting a redesigned device was defective and unsafe for use. According to a complaint filed on August 27th in the U.S. District Court, Eastern District of Louisiana, … Continue reading

Former FDA Commissioner to Testify at First Taxotere Hair Loss Trial

The federal judge overseeing thousands of Taxotere lawsuits involving allegations of permanent hair loss will allow a former U.S. Food & Drug Administration (FDA) commissioner to testify for the plaintiff during the litigation’s first bellwether trial. Dr. David Kessler’s Expected … Continue reading

Florida Sex Trafficking Law Targets Hotels and Spas

A recently passed Florida sex trafficking law aims to combat exploitation at hotels and spas throughout the state What Florida’s Sex Trafficking Law Does The legislation, which was signed by Florida’s governor in June, requires all hotel and spa staff to … Continue reading

Johnson & Johnson Hit With $37.3 Million Talcum Powder Cancer Verdict

Four plaintiffs who claim Johnson & Johnson’s Baby Powder caused their mesothelioma were awarded $37.3 million on Wednesday, after a New Jersey jury found that the popular product was tainted with asbestos and defective as sold. According to, the … Continue reading

Parties to Proton Pump Inhibitor Lawsuits at Odds Over Bellwether Trial Selections

The federal court overseeing thousands of kidney injury lawsuits involving Nexium, Prilosec, and other popular proton pump inhibitors is preparing to select candidates for planned bellwether trials. Unfortunately, it seems that attorneys for plaintiffs and defendants are at odd over … Continue reading

Follow Us on Google+ on Facebook on LinkedIn on Twitter on YouTube on Pinterest